Dopamine infusions have been shown to induce a significant reduction in LH levels in humans, and bromocriptine, a dopamine agonist, has demonstrated efficacy in reducing LH/FSH ratios and restoring ovarian function in women with PCOS [64, 78]. This evidence concerns the gene BRD2 and polycystic ovary syndrome.